載入...
Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005–13
Background: Erythropoiesis-stimulating agents (ESAs) with intravenous iron supplementation are the main treatment for anaemia in patients with chronic kidney disease. Although observational studies suggest better outcomes for patients who achieve higher haemoglobin (Hb) levels, randomized controlled...
Na minha lista:
| 發表在: | Nephrol Dial Transplant |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410985/ https://ncbi.nlm.nih.gov/pubmed/27190350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw043 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|